Adherence Monitoring For Substance Abuse Clinical Trials

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

8 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-01-31

Study Completion Date

2013-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the feasibility and accuracy of an automated adherence monitoring system, and to compare the variance between urine and oral fluid riboflavin levels when specimens are obtained 'as usual' and after a one-hour inter specimen interval.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Application Based Addiction Treatment Adherence Trial

NCT04680741

Opiate Use Disorder

COMPLETED NA

Attention Training for Opioid-maintained Cocaine Users

NCT01870882

Addiction Cocaine Methadone +1 more

COMPLETED PHASE4

Project I Test: Implementing HIV Testing in Opioid Treatment Programs

NCT03135886

HIV/AIDS Hepatitis C Substance Use Disorders +1 more

RECRUITING NA

SMART Trial for Buprenorphine-Naloxone Medication Assisted Treatment Adherence

NCT04080180

Opioid-use Disorder

COMPLETED NA

Effectiveness of Opiate Replacement Therapy Administered Prior to Release From a Correctional Facility - 1

NCT00142935

HIV Prevention Opioid-Related Disorders

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Medication Adherence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy Normals

Automated Adherence Monitoring System

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Automated Adherence Monitoring System

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female, aged 18 to 60
* Ability to give informed consent.
* Be willing and able to use the study-provided phone for taking and transmitting capsule photos.

Exclusion Criteria

* Unwilling or unable to use a cell phone.
* Any medical, psychiatric, or other condition that, in the opinion of the investigator, would preclude safe, consistent, or useful participation in the study.

Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes